Similar articles

• Protein kinase C - a family of protein kinases, allosteric effectors or both?

  Cameron AJ, Parker PJ. Cameron AJ, et al. Adv Enzyme Regul. 2010;50(1):169-77. doi: 10.1016/j.advenzreg.2009.10.004. Epub 2009 Nov 13. Adv Enzyme Regul. 2010. PMID: 19914278 Review. No abstract available.
• Applications of inhibitors for protein kinase C and their isoforms.

  Shen GX, Way KJ, Jacobs JR, King GL. Shen GX, et al. Methods Mol Biol. 2003;233:397-422. doi: 10.1385/1-59259-397-6:397. Methods Mol Biol. 2003. PMID: 12840525 No abstract available.
• Protein kinase C intervention: the state of play.

  Roffey J, Rosse C, Linch M, Hibbert A, McDonald NQ, Parker PJ. Roffey J, et al. Curr Opin Cell Biol. 2009 Apr;21(2):268-79. doi: 10.1016/j.ceb.2009.01.019. Epub 2009 Feb 23. Curr Opin Cell Biol. 2009. PMID: 19233632 Review.
• Protein kinase C phosphorylation: an introduction.

  Parker PJ. Parker PJ. Methods Mol Biol. 2003;233:159-62. doi: 10.1385/1-59259-397-6:159. Methods Mol Biol. 2003. PMID: 12840505 No abstract available.
• Relevance of atypical protein kinase C isotypes to the drug discovery process.

  Jenny M, Wrulich OA, Schwaiger W, Ueberall F. Jenny M, et al. Chembiochem. 2005 Mar;6(3):491-9. doi: 10.1002/cbic.200400186. Chembiochem. 2005. PMID: 15712318 Review. No abstract available.